Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:57:22 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



T:APLI - APPILI THERAPEUTICS INC. J - http://www.appilitherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
APLI - T  76.00.035·0.04312.00.0357.4090.035  0.04  0.0350.08  0.02515:26:53Apr 2615 min RT 2¢
TSX - T76.00.035·0.04312.00.0350.0044    0.08  0.025May 0615 min
NEO ATS - U 0.0354.0010.035  0.035  0.03512:09:0415 min
Omega - O 0.0352.010.035  0.035  0.03515:26:5315 min
Pure - P 0.0350.081    Oct 0515 min
CX2 - H 0.04+0.00514.31.010.04  0.04  0.0415:09:2815 min
TriAct - M 0.0350.41    Sep 11/2015 min

Recent Trades - All 9 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:26:53O0.035 2,0001 Anonymous1 AnonymousK
15:26:53M0.035 3627 TD Sec7 TD SecE
15:09:28H0.040.0051,00080 National Bank1 AnonymousK
12:09:04U0.035 4,0001 Anonymous76 iAK
12:09:04P0.035 757 TD Sec76 iAE
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-26 19:11C:APLI0.04News ReleaseAppili Therapeutics receives $300,000 bridge loan
2024-04-02 11:36C:APLI0.035News ReleaseAppili Therapeutics to be acquired by Aditxt
2024-03-12 10:04C:APLI0.035News ReleaseAppili researcher publishes manuscript on tularemia
2024-02-13 22:18C:APLI0.025SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-13 22:13C:APLI0.025SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-02-13 17:57C:APLI0.025News ReleaseAppili has Dec. 31 cash position of $600,000
2023-12-15 10:13C:APLI0.04News ReleaseAppili Therapeutics partner receives ATI-1701 patent
2023-11-14 15:57C:APLI0.035SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-14 15:55C:APLI0.035SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-13 16:46C:APLI0.035News ReleaseAppili has Sept. 30 cash position of $400,000
2023-10-25 10:08C:APLI0.035News ReleaseAppili to receive further funding for ATI-1701
2023-09-27 19:27C:APLI0.055News ReleaseAppili shareholders approve all matters at AGM
2023-09-25 10:30C:APLI0.065News ReleaseAppili partner receives U.S. FDA OK for ATI-1501
2023-08-11 18:30C:APLI0.045SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-11 17:01C:APLI0.045News ReleaseAppili Therapeutics has cash of $500,000 at June 30
2023-06-29 12:46C:APLI0.04News ReleaseAppili Therapeutics arranges $300,000 bridge loan
2023-06-23 10:28C:APLI0.035News ReleaseAppili has cash of $2.5-million at end of fiscal 2023
2023-06-23 09:14C:APLI0.035SEDAR Annual Information FormSEDAR Annual Information Form
2023-06-23 08:54C:APLI0.035SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-06-23 08:05C:APLI0.035SEDAR MD & ASEDAR MD & A